Medical Provider Single Use EZ Flu Shot 2018-2019
- Manufacturer
- Asclemed USA, Inc.
- Effective date
- 2018-08-31
- Label type
- VACCINE LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:52:11
Label at a glance#
ProductMedical Provider Single Use EZ Flu Shot 2018-2019
Active ingredientINFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTON..., INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTI..., INFLUENZA B VIRUS B/UTAH/9/2014 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/HONG KONG/259/2010 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), Isopropyl Alcohol
Label structure1 sections
FDA-Initiated Inactive NDC Indexing#
Products#
Every source-derived product name is available through these pages.
DailyMed product names page 1 of 1 · 19 matching rows.
- Medical Provider Single Use EZ Flu Shot 2018-2019
- influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/singapore/gp2050/2015 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/utah/9/2014 hemagglutinin antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/hong kong/259/2010 hemagglutinin antigen (mdck cell derived, propiolactone inactivated), Isopropyl Alcohol
- FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)
- influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/singapore/gp2050/2015 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/utah/9/2014 hemagglutinin antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/hong kong/259/2010 hemagglutinin antigen (mdck cell derived, propiolactone inactivated)
- INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA B VIRUS B/UTAH/9/2014 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA B VIRUS B/HONG KONG/259/2010 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- INFLUENZA B VIRUS B/HONG KONG/259/2010 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- POTASSIUM CHLORIDE
- SODIUM CHLORIDE
- MAGNESIUM CHLORIDE
- SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
- POTASSIUM PHOSPHATE, MONOBASIC
- WATER
- Isopropyl Alcohol
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125408 | Flucelvax, Flucelvax Quadrivalent | Influenza Vaccine | 351(a) | Disc | 2026-09-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
DailyMed ingredient rows page 1 of 1 · 12 matching rows.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.